S&P 500   2,995.72 (+0.00%)
DOW   27,019.02 (-0.02%)
QQQ   193.34 (-0.09%)
AAPL   234.68 (-0.27%)
FB   188.79 (-0.05%)
GOOGL   1,253.00 (+0.87%)
AMZN   1,785.35 (+1.02%)
CGC   19.74 (-1.79%)
NVDA   198.10 (+0.88%)
BABA   176.08 (+0.45%)
GE   9.01 (+1.35%)
TSLA   261.59 (+1.43%)
AMD   31.31 (+1.92%)
F   9.13 (+0.55%)
BAC   30.40 (+2.25%)
GILD   65.66 (+0.55%)
DIS   130.71 (+0.73%)
S&P 500   2,995.72 (+0.00%)
DOW   27,019.02 (-0.02%)
QQQ   193.34 (-0.09%)
AAPL   234.68 (-0.27%)
FB   188.79 (-0.05%)
GOOGL   1,253.00 (+0.87%)
AMZN   1,785.35 (+1.02%)
CGC   19.74 (-1.79%)
NVDA   198.10 (+0.88%)
BABA   176.08 (+0.45%)
GE   9.01 (+1.35%)
TSLA   261.59 (+1.43%)
AMD   31.31 (+1.92%)
F   9.13 (+0.55%)
BAC   30.40 (+2.25%)
GILD   65.66 (+0.55%)
DIS   130.71 (+0.73%)
Log in

Rite Aid Stock Price, News & Analysis (NYSE:RAD)

$9.08
-0.13 (-1.41 %)
(As of 10/16/2019 11:09 AM ET)
Today's Range
$8.99
Now: $9.08
$9.43
50-Day Range
$5.17
MA: $7.46
$9.89
52-Week Range
$5.04
Now: $9.08
$27.20
Volume14,565 shs
Average Volume3.58 million shs
Market Capitalization$498.31 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
CUSIP76775410
Phone717-761-2633

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.64 billion
Cash Flow$13.35 per share
Book Value$21.98 per share

Profitability

Net Income$-422,210,000.00

Miscellaneous

Employees51,000
Market Cap$498.31 million
Next Earnings Date12/18/2019 (Estimated)
OptionableOptionable

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.


Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Shares of Rite Aid reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Thursday, September, 26th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.08 by $0.04. The company earned $5.37 billion during the quarter, compared to analyst estimates of $5.41 billion. Rite Aid had a negative net margin of 2.12% and a positive return on equity of 0.02%. The firm's revenue for the quarter was down 1.0% compared to the same quarter last year. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Wednesday, December 18th 2019. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its FY20 earnings guidance on Thursday, September, 26th. The company provided earnings per share guidance of $0.00-0.56 for the period, compared to the Thomson Reuters consensus EPS estimate of ($0.05). The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $21.63 billion.

What price target have analysts set for RAD?

4 equities research analysts have issued twelve-month target prices for Rite Aid's stock. Their predictions range from $5.00 to $20.00. On average, they expect Rite Aid's stock price to reach $12.50 in the next year. This suggests a possible upside of 37.7% from the stock's current price. View Analyst Price Targets for Rite Aid.

What is the consensus analysts' recommendation for Rite Aid?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 sell ratings and 1 hold rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rite Aid.

Has Rite Aid been receiving favorable news coverage?

Headlines about RAD stock have been trending very negative this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rite Aid earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an effect on the stock's share price in the near term. View News Stories for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 16,370,000 shares, an increase of 19.8% from the August 30th total of 13,660,000 shares. Based on an average trading volume of 2,710,000 shares, the days-to-cover ratio is currently 6.0 days. Currently, 31.0% of the company's shares are sold short. View Rite Aid's Current Options Chain.

Who are some of Rite Aid's key competitors?

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), Lantronix (LTRX), General Electric (ge) and AK Steel (AKS).

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:
  • Mr. John T. Standley, CEO & Director (Age 56)
  • Mr. Kermit Ray Crawford, Pres & COO (Age 60)
  • Mr. Bryan B. Everett, Chief Operating Officer (Age 46)
  • Mr. Darren Wayne Karst, Exec. Officer (Age 59)
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy & Retail Operations (Age 49)

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $9.08.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $498.31 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe.View Additional Information About Rite Aid.

What is Rite Aid's official website?

The official website for Rite Aid is http://www.riteaid.com/.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]


MarketBeat Community Rating for Rite Aid (NYSE RAD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  663 (Vote Outperform)
Underperform Votes:  662 (Vote Underperform)
Total Votes:  1,325
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel